Frankfurt - Delayed Quote EUR
4SC AG (VSC.F)
2.0000
-0.2500
(-11.11%)
At close: May 9 at 9:17:07 AM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-7,507
-7,507
-9,548
-9,383
-12,069
Investing Cash Flow
-2
-2
47
104
-34
Financing Cash Flow
7,500
7,500
3,000
0
0
End Cash Position
8,311
8,311
8,320
14,821
24,100
Capital Expenditure
-2
-2
-2
-3
-34
Issuance of Capital Stock
4,000
4,000
0
0
0
Issuance of Debt
3,500
3,500
3,000
0
--
Repurchase of Capital Stock
--
--
--
--
0
Free Cash Flow
-7,509
-7,509
-9,550
-9,386
-12,103
12/31/2021 - 12/15/2005
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BSLN.SW Basilea Pharmaceutica AG
44.40
+0.34%
MDG1.DE Medigene AG
0.1335
-27.64%
IDIA.SW Idorsia Ltd
1.2820
-2.88%
UCB.BR UCB SA
154.35
+1.78%
NKTR Nektar Therapeutics
0.5887
-4.88%
IONS Ionis Pharmaceuticals, Inc.
32.26
-1.50%
BNTX BioNTech SE
92.77
-2.12%
REGN Regeneron Pharmaceuticals, Inc.
527.78
-3.63%
RXRX Recursion Pharmaceuticals, Inc.
4.3300
-1.37%
VRTX Vertex Pharmaceuticals Incorporated
424.99
-1.07%